You need JavaScript to view this

Mammary neoplasm inflammatory: clinic presentation: combined treatment value; Cancer inflamatorio de mama: presentacion clinica: valor de los tratamientos combinados

Journal Article:

Abstract

On a total of 1152 patients bearing of cancer of she suckles tried in the period 1978-1988, 41 of she(3.5% )corresponding to the variety inflamatory. Her ages was understood between 26 and 73 years , was been 15(63,5% )postmenopause. Clinically they presented commitment mammary exclusive 34,1%, invasion ganglionar lorregional 48,7% and 17% was disseminated remaining. The initial treatment bases on 3-4 cycles of chemotherapy type FCA, safe in patient with more years that they received the association CMF. All then were irradiated with dose of 5000-6000 cGy on she suckles and territories ganglionares. Finish the treatment with 6 to 8 additional cycles of the patients' chemotherapy. Nobody it was subjected to surgical. The middle survive of the population's total it was of 22 meses, has been of 26 for the premenopause and 15 for the posmenopause. The percentage of relapses arrive to 30% and 45% in the located ways they were disseminated during its evolution. It highlights that the therapeutic strategy you bases on the association open chemotherapy, radiotherapy remaining the possibility of the handling of high citostatics dose with or without transplants of osseous medulla osea (Author) [Spanish] Sobre un total de 1152 pacientes portadoras de cancer de mama  More>>
Publication Date:
Jun 01, 1995
Product Type:
Journal Article
Report Number:
INIS-UY-1.1
Reference Number:
EDB-00:079748
Resource Relation:
Journal Name: Cirugia del Uruguay; Journal Volume: 65; Journal Issue: 2; Other Information: PBD: Apr-Jun 1995
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; CHEMOTHERAPY; EVALUATION; MAMMARY GLANDS; NEOPLASMS; RADIOTHERAPY; THERAPEUTIC USES
OSTI ID:
20087459
Country of Origin:
Uruguay
Language:
Spanish
Other Identifying Numbers:
Journal ID: ISSN 0009-7381; CRGUAT; TRN: UY0000019039822
Availability:
Also available from BINAME Library;INIS
Submitting Site:
INIS
Size:
page(s) 111-116
Announcement Date:

Journal Article:

Citation Formats

Viola Alles, A, Sabini Gaye, G, Barrios Herrera, E, and Muse Sevrini, I. Mammary neoplasm inflammatory: clinic presentation: combined treatment value; Cancer inflamatorio de mama: presentacion clinica: valor de los tratamientos combinados. Uruguay: N. p., 1995. Web.
Viola Alles, A, Sabini Gaye, G, Barrios Herrera, E, & Muse Sevrini, I. Mammary neoplasm inflammatory: clinic presentation: combined treatment value; Cancer inflamatorio de mama: presentacion clinica: valor de los tratamientos combinados. Uruguay.
Viola Alles, A, Sabini Gaye, G, Barrios Herrera, E, and Muse Sevrini, I. 1995. "Mammary neoplasm inflammatory: clinic presentation: combined treatment value; Cancer inflamatorio de mama: presentacion clinica: valor de los tratamientos combinados." Uruguay.
@misc{etde_20087459,
title = {Mammary neoplasm inflammatory: clinic presentation: combined treatment value; Cancer inflamatorio de mama: presentacion clinica: valor de los tratamientos combinados}
author = {Viola Alles, A, Sabini Gaye, G, Barrios Herrera, E, and Muse Sevrini, I}
abstractNote = {On a total of 1152 patients bearing of cancer of she suckles tried in the period 1978-1988, 41 of she(3.5% )corresponding to the variety inflamatory. Her ages was understood between 26 and 73 years , was been 15(63,5% )postmenopause. Clinically they presented commitment mammary exclusive 34,1%, invasion ganglionar lorregional 48,7% and 17% was disseminated remaining. The initial treatment bases on 3-4 cycles of chemotherapy type FCA, safe in patient with more years that they received the association CMF. All then were irradiated with dose of 5000-6000 cGy on she suckles and territories ganglionares. Finish the treatment with 6 to 8 additional cycles of the patients' chemotherapy. Nobody it was subjected to surgical. The middle survive of the population's total it was of 22 meses, has been of 26 for the premenopause and 15 for the posmenopause. The percentage of relapses arrive to 30% and 45% in the located ways they were disseminated during its evolution. It highlights that the therapeutic strategy you bases on the association open chemotherapy, radiotherapy remaining the possibility of the handling of high citostatics dose with or without transplants of osseous medulla osea (Author) [Spanish] Sobre un total de 1152 pacientes portadoras de cancer de mama tratadas en el periodo 1978-1988, 41 de ellas(3.5%)correspondieron a la variedad inflamatoria. Sus edades estaban comprendidas entre 26 y 73 an os,siendo 15(63,5%) posmenopausicas. Clinicamente presentaron compromiso mamario exclusivo 34,1%, invasion ganglionar lorregional 48,7% y estaban diseminadas 17% resptantes. El tratamiento inicial se baso en 3-4 ciclos de quimioterapia tipo FCA, salvo en pacientes anosas que recibieron la asociacion CMF. Todas ellas luego se irradiaron con dosis de 5000-6000 cGy sobre mama y territorios ganglionares. Se culmino el tratamiento con 6 a 8 ciclos adicionales de quimioterapia. Ninguna de las pacientes fue sometida a cirugia. La sobrevida media del total de la poblacion fue de 22 meses, siendo de 26 para las premenopausicas y 15 para las posmenopausicas. El porcentaje de recidivas llego al 30 % y 45% de las formas localizadas se diseminaron durante su evolucion. Se destaca que la estrategia terapeutica se baso en la asociacion qumio-radioterapia, quedando abierta la posibilidad del manejo de altas dosis de citostaticos con o sin trasplantes de madula osea(Au)}
journal = {Cirugia del Uruguay}
issue = {2}
volume = {65}
journal type = {AC}
place = {Uruguay}
year = {1995}
month = {Jun}
}